Inhaled triple therapy and airway hyperresponsiveness in persistent asthma

Brian Lipworth; Chris RuiWen Kuo; Sunny Jabbal; Rory Chan

doi:10.1016/j.anai.2021.01.032

Inhaled triple therapy and airway hyperresponsiveness in persistent asthma

Brian Lipworth (Lead / Corresponding author), Chris RuiWen Kuo, Sunny Jabbal, Rory Chan

Molecular and Clinical Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	597-598
Number of pages	2
Journal	Annals of Allergy, Asthma and Immunology
Volume	126
Issue number	5
Early online date	3 Feb 2021
DOIs	https://doi.org/10.1016/j.anai.2021.01.032
Publication status	Published - 1 May 2021

Keywords

Asthma
airway hyperresponsiveness
mannitol
long acting muscarinic antagonist

Access to Document

10.1016/j.anai.2021.01.032Licence: Elsevier User Licence

Cite this

@article{2f25ef9a5fee416c9b05db4890661e2d,

title = "Inhaled triple therapy and airway hyperresponsiveness in persistent asthma",

keywords = "Asthma, airway hyperresponsiveness, mannitol, long acting muscarinic antagonist",

author = "Brian Lipworth and Kuo, {Chris RuiWen} and Sunny Jabbal and Rory Chan",

year = "2021",

month = may,

day = "1",

doi = "10.1016/j.anai.2021.01.032",

language = "English",

volume = "126",

pages = "597--598",

journal = "Annals of Allergy, Asthma and Immunology",

issn = "1081-1206",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Inhaled triple therapy and airway hyperresponsiveness in persistent asthma

AU - Lipworth, Brian

AU - Kuo, Chris RuiWen

AU - Jabbal, Sunny

AU - Chan, Rory

PY - 2021/5/1

Y1 - 2021/5/1

KW - Asthma

KW - airway hyperresponsiveness

KW - mannitol

KW - long acting muscarinic antagonist

U2 - 10.1016/j.anai.2021.01.032

DO - 10.1016/j.anai.2021.01.032

M3 - Letter

C2 - 33548471

VL - 126

SP - 597

EP - 598

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 5

ER -